
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
Miguel Á. Luján, Adriana Castro‐Zavala, Laia Alegre-Zurano, et al.
Neuropharmacology (2018) Vol. 143, pp. 163-175
Closed Access | Times Cited: 119
Miguel Á. Luján, Adriana Castro‐Zavala, Laia Alegre-Zurano, et al.
Neuropharmacology (2018) Vol. 143, pp. 163-175
Closed Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Ewa Galaj, Guo‐Hua Bi, Hongju Yang, et al.
Neuropharmacology (2019) Vol. 167, pp. 107740-107740
Open Access | Times Cited: 106
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70
Glial Cell AMPA Receptors in Nervous System Health, Injury and Disease
María Ceprián, Daniel Fulton
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2450-2450
Open Access | Times Cited: 59
María Ceprián, Daniel Fulton
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2450-2450
Open Access | Times Cited: 59
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Nicole M. Wanner, Mathia Colwell, Chelsea Drown, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Nicole M. Wanner, Mathia Colwell, Chelsea Drown, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake
Miguel Á. Luján, Lídia Cantacorps, Olga Valverde
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 48
Miguel Á. Luján, Lídia Cantacorps, Olga Valverde
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 48
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Carolina de Meneses-Gaya, José Alexandre S. Crippa, Jaime E. C. Hallak, et al.
Brazilian Journal of Psychiatry (2020) Vol. 43, Iss. 5, pp. 467-476
Open Access | Times Cited: 41
Carolina de Meneses-Gaya, José Alexandre S. Crippa, Jaime E. C. Hallak, et al.
Brazilian Journal of Psychiatry (2020) Vol. 43, Iss. 5, pp. 467-476
Open Access | Times Cited: 41
Cannabidiol in the context of substance use disorder treatment: A systematic review
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27
Cannabidiol abrogates cue-induced anxiety associated with normalization of mitochondria-specific transcripts and linoleic acid in the nucleus accumbens shell
Jacqueline‐Marie N. Ferland, Alexandra Chisholm, Jasmina Abdalla, et al.
Molecular Psychiatry (2025)
Closed Access
Jacqueline‐Marie N. Ferland, Alexandra Chisholm, Jasmina Abdalla, et al.
Molecular Psychiatry (2025)
Closed Access
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
Persistent behavioural consequences of chronic adolescent cannabidiol (CBD) in a mouse model with increased susceptibility to Δ9-tetrahydrocannabinol and schizophrenia
Gabriela Visini, Rose Chesworth, Tim Karl
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111306-111306
Closed Access
Gabriela Visini, Rose Chesworth, Tim Karl
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111306-111306
Closed Access
Cannabidiol inhibits sucrose self‐administration by CB 1 and CB 2 receptor mechanisms in rodents
Guo‐Hua Bi, Ewa Galaj, Yi He, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 36
Guo‐Hua Bi, Ewa Galaj, Yi He, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 36
Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol
Cristian Bis‐Humbert, Rubén García‐Cabrerizo, M. Julia García‐Fuster
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1621-1631
Closed Access | Times Cited: 36
Cristian Bis‐Humbert, Rubén García‐Cabrerizo, M. Julia García‐Fuster
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1621-1631
Closed Access | Times Cited: 36
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats
Genmeng Yang, Liu Liu, Ruilin Zhang, et al.
Toxicology Research (2020) Vol. 9, Iss. 3, pp. 202-211
Open Access | Times Cited: 32
Genmeng Yang, Liu Liu, Ruilin Zhang, et al.
Toxicology Research (2020) Vol. 9, Iss. 3, pp. 202-211
Open Access | Times Cited: 32
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Franciele Franco Scarante, Melissa A. Ribeiro, Ana Flávia Almeida-Santos, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Franciele Franco Scarante, Melissa A. Ribeiro, Ana Flávia Almeida-Santos, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat
Mahsa Anooshe, Kiana Nouri, Saeideh Karimi‐Haghighi, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113158-113158
Closed Access | Times Cited: 29
Mahsa Anooshe, Kiana Nouri, Saeideh Karimi‐Haghighi, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113158-113158
Closed Access | Times Cited: 29
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Intermittent-Excessive and Chronic-Moderate Ethanol Intake during Adolescence Impair Spatial Learning, Memory and Cognitive Flexibility in the Adulthood
Ana Contreras, Eduardo Polín, Miguel Miguéns, et al.
Neuroscience (2019) Vol. 418, pp. 205-217
Closed Access | Times Cited: 31
Ana Contreras, Eduardo Polín, Miguel Miguéns, et al.
Neuroscience (2019) Vol. 418, pp. 205-217
Closed Access | Times Cited: 31
Sex differences in the vulnerability to cocaine's addictive effects after early-life stress in mice
Adriana Castro‐Zavala, Ana Martín‐Sánchez, Olga Valverde
European Neuropsychopharmacology (2020) Vol. 32, pp. 12-24
Closed Access | Times Cited: 28
Adriana Castro‐Zavala, Ana Martín‐Sánchez, Olga Valverde
European Neuropsychopharmacology (2020) Vol. 32, pp. 12-24
Closed Access | Times Cited: 28
The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders
Miguel Á. Luján, Olga Valverde
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28
Miguel Á. Luján, Olga Valverde
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28
Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal
Ani Gasparyan, Francisco Navarrete, Marta Rodrı́guez-Arias, et al.
Neurotherapeutics (2020) Vol. 18, Iss. 1, pp. 615-623
Open Access | Times Cited: 28
Ani Gasparyan, Francisco Navarrete, Marta Rodrı́guez-Arias, et al.
Neurotherapeutics (2020) Vol. 18, Iss. 1, pp. 615-623
Open Access | Times Cited: 28